A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity

Stopped Cancelled before Active

Conditions

• Dentin Sensitivity

Interventions

• DRUG: Dentifrice containing 5% w/w KNO3 and 0.454% w/w SnF2 (1100 ppm fluoride).
• DRUG: Dentifrice containing 0.454% w/w SnF2 (1100 ppm fluoride).

Sponsor

GlaxoSmithKline